KYMAB - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88441516
Serial Number
88441516
Registration Number
6473731
Word Mark
KYMAB
Status
700 - Registered
Status Date
2021-09-07
Filing Date
2019-05-22
Registration Number
6473731
Registration Date
2021-09-07
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2021-03-23
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
MANGUBAT, ALEXANDER GE
Statements
Goods and Services
Pharmaceutical and medical preparations containing monoclonal antibodies for the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; Veterinary preparations containing monoclonal antibodies for treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, autoimmune and infectious diseases, and medical diagnostics; sanitary preparations containing monoclonal antibodies for medical purposes; dietetic food and beverages containing monoclonal antibodies, for medical and veterinary use; dietary supplements containing monoclonal antibodies for human beings and animals; dietary supplements containing monoclonal antibodies; Pharmaceutical preparations containing monoclonal antibodies for the treatment of treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases and in the field of antibodies and immuno-oncology
Goods and Services
Scientific, medical and technological services, namely, scientific research, analysis and testing in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology, and scientific research, analysis and testing in the field of antibodies and cell repertoires and research, development and design in the field of science, medicine, and technology; industrial analysis and industrial research services, namely, testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; design and development of computer hardware and software; design and development of hardware and software for analysis and testing in the field of antibodies and biological cells and genetic discovery and clinical development; Clinical research in the field of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; Conducting clinical trials for others in the field of antibodies, and medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; conducting clinical trials for pharmaceutical products for others in the field of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying of medical conditions, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics, and in the field of antibodies and immuno-oncology; scientific and medical screening and assaying in the field of genetic discovery, clinical development, antibodies and biological cells; chemical analysis; chemical research
Goods and Services
Medical services; diagnostic and prognostic medical services; veterinary services; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; pharmaceutical consultation in the nature of pharmacy advice; medical and health services in the nature of the treatment and prophylaxis of medical conditions in humans, namely, cancer, inflammatory, hematology, autoimmune and infectious diseases, and medical diagnostics; Medical screening
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-06-06
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-06-06
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-06-06
Primary Code
044
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Mark H. Tidman
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
2019-02-07UK0000337361United KingdomTrue
United KingdomFalse
UK0000337361True
UK0000337361United KingdomTrue
Trademark Events
Event DateEvent Description
2019-05-25NEW APPLICATION ENTERED IN TRAM
2019-06-06NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-08-09ASSIGNED TO EXAMINER
2019-08-09NON-FINAL ACTION WRITTEN
2019-08-09NON-FINAL ACTION E-MAILED
2019-08-09NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-01-28TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-01-28CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-01-29TEAS/EMAIL CORRESPONDENCE ENTERED
2020-02-14EXAMINERS AMENDMENT -WRITTEN
2020-02-14EXAMINERS AMENDMENT E-MAILED
2020-02-14NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2020-02-14EXAMINER'S AMENDMENT ENTERED
2020-02-14APPROVED FOR PUB - PRINCIPAL REGISTER
2020-02-21ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
2020-02-21ELECTRONIC RECORD REVIEW COMPLETE
2020-03-09PREVIOUS ALLOWANCE COUNT WITHDRAWN
2020-03-16NON-FINAL ACTION WRITTEN
2020-03-16NON-FINAL ACTION E-MAILED
2020-03-16NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-08-21TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-08-21CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-08-22TEAS/EMAIL CORRESPONDENCE ENTERED
2020-10-09NON-FINAL ACTION WRITTEN
2020-10-09NON-FINAL ACTION E-MAILED
2020-10-09NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-02-17EXAMINERS AMENDMENT -WRITTEN
2021-02-17EXAMINERS AMENDMENT E-MAILED
2021-02-17NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2021-02-17EXAMINER'S AMENDMENT ENTERED
2021-02-17APPROVED FOR PUB - PRINCIPAL REGISTER
2021-03-03NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2021-03-23PUBLISHED FOR OPPOSITION
2021-03-23OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2021-04-21EXTENSION OF TIME TO OPPOSE RECEIVED
2021-08-01EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
2021-09-07REGISTERED-PRINCIPAL REGISTER